课题基金 / 基金详情

PLACEBO CONTROLLED STUDY TO EVALUATE GANAXOLONE IN COMPLEX PARTIAL SEIZURES

PLACEBO CONTROLLED STUDY TO EVALUATE GANAXOLONE IN COMPLEX PARTIAL SEIZURES
评估加奈索酮治疗复杂部分性癫痫发作的安慰剂对照研究
批准号：
6276465
负责人：
KENNETH D LAXER
金额：
$6.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6276465
关键词：
adult human (21+) anticonvulsants brain disorder chemotherapy clinical research drug screening /evaluation electroencephalography hospital patient care human subject human therapy evaluation partial seizure placebos telemetry video recording system

项目摘要

项目成果

KENNETH D LAXER的其他基金

相似基金

相关文献

中文摘要
翻译
GNX 104是一项II期住院患者安慰剂对照单药治疗试验， 实验性抗惊厥药加奈索酮在成人难治性 已停用常规抗惊厥药的部分性癫痫 在此之前，在8 Long的例行住院期间， 脑电/视频遥测技术在外科手术中应用研究 癫痫的治疗这项研究将评估安全性，耐受性， 和加奈索酮的功效。
英文摘要
GNX 104 is a Phase II in-patient placebo-controlled monotherapy trial of the experimental anticonvulsant ganaxolone in adults with refractory partial epilepsy whose regular anti-convulsants have been discontinued during a routine hospital admission on 8 Long immediately preceding this study for EEG/video telemetry to determine their suitability for surgical treatment of seizures. The study will evaluate the safety, tolerability and efficacy of ganaxolone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
High Field Neuroimaging of Epilepsy
海外基金